Anxiety and Depression (MC) - Block 3 Flashcards

1
Q

The more lipophilic the drugs, the more its able to?

A
  1. PPB
  2. Have high Vd and DOA
  3. Have longer half-lives
  4. Rapidly absorb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Have active metabolites leads to ____?

A

accumulation of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What occurs during N-dealkylation?

A

3 amine to 2
2 amine to 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What occurs during MOA metabolism?

A

Primary amine to aldehyde

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the cause of serotonin syndrome?

A

When 2 agents that increase seratonin are taken together:
* If one is DC and has a long t1/2 it may need a wash out period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the sx of serotoninc syndrome?

A
  1. Fever
  2. Tremor
  3. Coma
  4. Sz
  5. Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the side effects that are caused by serotonin?

A

Depression
OCD
Panic
Bulimia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the side effects that are caused by too much serotonin?

A
  1. Anx
  2. Insomnia
  3. Sexxual dysfunction
  4. GI disturbances
  5. Serotonin syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the function of serotonin and NE?

A

5HT + NE = parallel, independent pathways
5HT: changes in mood
NE: Increased drive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the overall function of reuptake inhibtiors?

A

Change presynaptic and postsynaptic sensitivity of neurons:
* Induces synaptic and neuronal plasticity in serotonergic and/or noradrenergic neurons -> long-term changes in neurochemistry
* 5-HT and NE modulate a large number of other neurotransmitter systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Decribe the underlying mechanism of reuptake inhibitors?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the onset of antidepressants?

A

Maximum benefit is not achieved till 1-2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe tserotonin reuptake before drug?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the immediate effects of SSRIs?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is lag time?

A

Elevated levels of NT -> inhibitory autoreceptor stimulation down regulates activity of rate-limiting enzymes TPH and TH -> reduces rate of neuronal firing
* Initial exporsure to antidepressants may not significantly increase postsynaptic signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the long term effects of SSRI?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does AD contribute to lag time?

A

Chronic use of antidepressants -> inhibitory autoreceptors are down-regulated -> enhancement of neurotransmission
* Drug causes gradual desensitization of autoreceptors -> increased neurotransmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lag time/delay is likely caused by?

A

Inhibitory feedback mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the long term effects of NE reuptake inhibition?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Is there one drug that can treat all patients with depression?

A

No, Some patients may respond better to serotonergic agent, others to noradrenergic agent. Some may respond to both

Selection of med is a guessing games and dependent on a patient’s response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the overall SAR and PK of TCAs?

A

SAR:
* 6-76 rings
* Side chain usually 3 carbon atoms with terminal amine (secondary or tertiary)

PK: very lipophilic -> high PPB and Vd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the selectivity of TCAs?

A

Tertiary: non-selective, dual affinity for NET and SERT
Secondary: selective for NET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does tert TCA selectivty contribute to ADRs?

A

Narrow therapeutic window with anticholinergic, antihistaminic, a1-antiadrenergic, cardiac, and weak dopamine reuptake blocking ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the metabolism of tert amine TCA?

A

Good absorption but low bioavailability due to extensive N-dealkylation to secondary amine TCAs (active metabolite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the types of tertiary amine TCAs?

A

Amitriptyline (Elavil)
Imipramine
Doxepin (Sinequam)
Chlorimipramine/Clomipramine
Trimipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe the selectivity of secondary amine TCAs?

A

More selective for NET – less anticholinergic/sedative:
* Narrow therapeutic-to-toxicity ratios due to heavy metabolism by CYPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the secondary TCAs and what are they a metabolite of?

A

Imipramine -> Desipramine
Amitriptyline -> Nortriptyline
Nortriptyline -> Protriptyline
Loxapine -> Amoxapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the selective secondary TCAs? Non-selective?

A

Selective: Desipramine, Protriptyline
Non-selective: Nortriptyline, amoxapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

TCAs DDI?

A

High PPB drugs, anticholinergic, sympathomimetic drugs
* Increased risk for serotonin syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

TCA metabolism?

A

CYP2D6 (genetic polymorphism and narror TI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What occur syndrome can occur from TCA besides serotonin syndrome?

A

Discontinuation syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are ADRs of TCAs?

A

Anticholinergic: Dry mouth, constipation, urinary retention, blurred vision
Antiadrenergic: Orthostatic hypotension (especially for elderly patients)
Antihistaminic: Weight gain, sedation
Sodium channels: Increased cardiotoxicity or frequency of seizures
Norepinephrine reuptake: sexual dysfunction
Serotonin reuptake: GI upset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is the endogenous ligand of SSRI?

A

Serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

How does SSRI differ from TCAs?

A
  1. High affinity and selectivity for the SERT
  2. Low affinity for receptors that cause ADRs of TCAs with larger TI
  3. No inhibiton of fast sodium chaneels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is the general characterisitcs of SSRI?

A
  1. High lipophilicity -> high absorption and PPB
  2. High Vd -> long DOA
  3. Long half-life
  4. High toxic to therapeutic ration
  5. Extensively metabolized by CYPs
  6. Steady-state plasma levels reached in 7 – 10 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

SAR of SSRI?

A

Electronegative para substitution -> good selectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What are you elecronegative groups?

A

Cl, I, F, B, CN, NO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

How does selectivity/affintiy differ in different SSRI drugs?

A

All equally effective over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

SSRIs

ADR, DDI

A

ADR: Increased serotonergic tone
DDI: Potential for serotonin syndrome with other serotonergic agents (i.e. MAOIs)
* Need washout for 2-5 weeks when switching SSRI to MAOI
* Sudden discontinuation -> discontinuation syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What are you seratonin side effects?

A

N, D, insomnia, HA, sexual dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is discontinuation syndrome?

A

DZ, paresthesias that occurs 2 days after abrupt drug withdrawal and generally resolves in 2-3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What is the the difference between SSRI and TCA ADRs?

A

SSRI: more NE and SE uptake inhibition ADRs
TCA: More anti-a1, antibholinergic, antihistamine ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Types of SSRIs?

A

Fluoxetine (Prozac, Sarafem)
Paroxetine (Paxel)
Citalopram (Celexa)
Escitalopram (Lexapro)
Sertraline (Zoloft)
Fluvoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Fluoxetine

PK, Cautions, What contributes to selectivity

A

Prozac, Saradem
PK: very long half life and inhibtis own metabolism (CYP2D6) and CYP2C19, CYP3A4
Caution: inhibiton of metabolism and long half-life -> long washout perioid with switching therapies
Selectivity: CF3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Paroxetine

PK, What contributes to selectivity

A

PK: Inhibits CYP2D6 irreversibly through mechanism based inhibition from reactive metabolite
* Non-linear/lang term effects
Selectivity: F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

How is Citalopram an improvement from other SSRIs?/

A

No first pass metabolism -> higher bioavailability
* Less PPB

47
Q

What is Lexapro?

A

S-enatiomer of citalopram that is more slective and active
* R-enantiomer conteracts S

48
Q

Between Lexapro and and Celexa which has a high ADR risk?

A

Citalopram because its a racemic mixture

49
Q

Citalopram

Selectivity

A

NC

50
Q

Sertraline

Selectivity, PK

A

Selectivity: Cl, Higher selectivity than other SSRIs or TCAs
PK: extensive metabolism
* Can decrease peak plasma concentration time from 8 to 6 hrs with food
* But metabolism is by a lot of enzymes -> less potential for DDIs

51
Q

How does fluvoxamine differ from other SSRIs?

A

Nontricyclic, only nonchiral (less potent)

52
Q

Fluvoxamine

Selectivity, PK

A

Selectivity: CF3
PK: nonlinear

53
Q

What are you nonlinear SSRI?

A

Fluoxetine
Paroxetine
Fluvoxamine

54
Q

What SSRI has least affect on CYPs?

A

Citalopram

55
Q

SNRI MOA?

A

Inhibits both NET and SERT -> combination produces greater efficacy
* Possesses low affinity at other neurotransmitter receptos -> low side effect potential

56
Q

SNRI

ADR

A
  1. Serotonergic effects
  2. Noradrenergic effects
  3. CNS activation
  4. DC syndrome
57
Q

TYpes of SNRI?

A
  1. Venlafaxine (Effexor)
  2. Desvenlafaxine (Pristiq, Kedezla)
  3. Levomilacprin
  4. Duloxetine (Cymbalta)
58
Q

Venlafaxine

MOA, ADR, PK

A

MOA: Preferentially inhibits 5-HT reuptake over NE and DA reuptake
ADR: Low risk for AE, but can have ardiotoxcity
PK: low bioavailability
* Weak inhibitor of CYP2D6

59
Q

How does desvenlafaxine differ from venlafaxine? ADR?

A

Equiactive metabolite with hydroxyl group
ADR: N

60
Q

Levomilnacprin

MOA, PK, ADR

A

MOA: Higher affinity for 5-HT reuptake
PK: Slower onset of action than TCAs
ADR: Generally safe

61
Q

Duloxetine

MOA, PK, ADR

A

MOA: slightly higher affinity for SERT
PK: CYP2D6 inhibitor and produces
ADR: reactive metabolite causes jaundice like conditions

62
Q

What is first MOAI?

A

Isoniazid: Antitubercular

63
Q

What are the cons of using MAOIs?

A

Hepatotox due to hydrazine reactive group

64
Q

Why could MAOI be consequenctial?

A

Many drugs are metabolized by MAOI, inhibition leads to accumulation

65
Q

Describe the potential of MAOIs?

A

Irreversible inactivation, effects can be seen up to 2 weeks after dc the drug

Onset takes a few days

66
Q

Describe the MOA of MAOIs?

A
67
Q

What are the effects of irreversible MOA-A and B inhibition?

A
  1. Increase free 5-HT and NE, and other amines
68
Q

Types of MOA irreversible inhibitors?

A

Phenelzine
Isocarboxazid
Tranylcypromine
Selegiline

69
Q

MOA irreversible inhibitors SAR?

A
  • Message: Contains reactive groups that form irriversible bonds to FAD
  • Contains an address: directs drug to MOA
70
Q

What are the metabolism issues with tranylcypromine?

A

Inhibits other metabolizing enzymes (MAO, CYP2C19, 2D6, 2C9)

71
Q

What is the metabolism issue with phenelzine?

A

Interindividual variability in plasma concentrations due to slow/fast acetylators

72
Q

What is the metabolism issue with selegiline?

A

Metabolized to meth/amphetampine by CYP2B6 and CYP3A4

73
Q

MOAI

ADR, DDI

A

ADI: orthostatic hypotension, weight gain, sexual dysfunction, insomnia, sudden DC syndrome
DDI:interactions with food -> hypertensive crisis from increased catecholamines
* Foods with large amounts of tyrramine or tryptophan

74
Q

What are the sx of HTN crisis?

A

HA, tachycardia, cardia arrhythmia, stroke

75
Q

How does Moclobemide differ from other MAOIs?

A

Reversible MAO-A inhibitor antidepressant (RIMA): can be displaced by tyramine if ingested

76
Q

What are natural DA and NE Reuptake Inhibitors?

A

CNS stimulants: methamphetamine, diethylpropion, cathinone

77
Q

What DA and NE Reuptake Inhibitor is designed to have no metabolites with sympathomimetic or anorexigenic properties?

A

Bupropion due to T-butyl group -> no N-dealkylation

78
Q

What are the considerations of DA and NE Reuptake Inhibitors?

A

ADR: sympathomimetic and/or anorexigenic (N-dealkylation)

Extensive metabolism to active metabolites with long DOA

79
Q

Bupropion

MOA, PK, ADR

A

Aplenzin, Forfivo, Wellbutrin
MOA: Bupropion inhibits DA reuptake at DA presynaptic neuronal membrane and inhibits release of DA and NE; also noncompetitive antagonist of several nAChRs
* Plasma concentrations are higher than parent drug with longer DOA
* Similar pharmacologic properties to bupropion

PK: CYP2D6 inhibitor
ADR: Risk of serious seizures with antiseizures, insomnia, N,DZ, tremor
* NO sexual dysfunction due to no serotonin activity

80
Q

What is an example NMDA antagonist for psch?

A

Auxility (dextromethorphan-bupropion)

81
Q

Auxillary

MOA, ADR

A

Dextromethorphan: active at NMDA receptor and σ-1 receptor (heavily metabolized by CYP2D6)
Bupropion: Inhibits CYP2D6
ADR: seratonin sx for dex

82
Q

What is the function of Serotonin Receptor Modulators?

A

Modulate concnetration of 5-HT in brain:
* Receptors can also modulate other neurotransmitters
* Enhance noradrenergic or serotonergic transmission

83
Q

MOA of SRMs?

A
  • 5-HT2A antagonist and reuptake inhibitor; active metabolite is 5-HT2c agonist
  • α1-adrenergic antagonist but doesn’t affect DA or NE reuptake, little anticholinergic activity, no cardiovascular toxicity
84
Q

SAR of SRM?

A

Serotonin Receptor Modulators = phenylpiperazines

However, open para postition can need to hepatotoxicity

85
Q

Examples of SRM?

A

Trazodone
Nefazodone
Vortioxetine
Vilazodone (Viibryd)
Mirtazapine (Remeron)

86
Q

Trazodone

ADR

A

Desyrel
ADR: Hypotension, high sedation (difficult to titrate to AD doses), GI, hepatotoxic (2 reactive metabolites)

87
Q

Describe the metabolism of trazodone?

A
88
Q

Nefazodone

BBW, PK, ADR

A

BBW: hepatotoxic due to open para across N
PK: potent CYP3A4 inhibitor
ADR: Sedation, GI disturbances, orthostatic hypotension (α1-adrenergic antagonist)
* Less sedation than trazodone

89
Q

Vortioxetine

MOA, PK, ADR

A

MOA: Antagonist at 5-HT3, 5-HT7 and 5-HT1D, partial agonist at 5-HT1B, agonist at 5-HT1A; and reuptake inhibitor
PK: Metabolized by CYP2D6
ADR: GI effects, sexual dysfunction, headaches, insomnia

90
Q

Vilazodone

MOA, ADR, BBW, DDI, PK

A

Viibryd
MOA: selective 5-HT1A receptor partial agonist (1 week onset of action) and reuptake inhibitor
ADR: Diarrhea, nausea, vomiting, sexual dysfunction
BBW: Suicidal ideation in young adults and children
DDI: NSAIDs/warfarin
PK: Extensively metabolized by CYP3A4

91
Q

Mirtazapine

MOA, ADR, Indication

A

Remeron
MOA: α2-adrenergic antagonist (increases release of NE) and 5-HT2 and 5-HT3 antagonist
* NaSSA – noradrenergic and specific serotonin antidepressant

ADR: anticholinergic, H1 receptor antagonist (-> sedation) and α1-adrenergic antagonist (-> orthostatic hypotension)
* Take at HS to avoid daytime sedation

Indication: Potent appetite stimulant -> weigh gain

92
Q

What are the general concepts of AD?

A
  1. Equal efficacy
  2. Risk of increased suicidality
  3. Lethal OD more common with MAOIs and TCAs
  4. Nearly all metabolized by ≥ 1 CYP
    * If > 1 in parallel -> unlikely to be affected by DDIs or polymorphisms
    * If CYP3A4, CYP2C18 or CYP2D6 -> potential for DDIs increases
93
Q

Describe the sx remission timeline?

A
94
Q

What drugs have the highest incidence for sexual disfunction?

A

SSRIs, SNRIs and MAOIs (especially paroxetine)

95
Q

What drugs have the lowest incidence for sexual dysfunction?

A

Bupropion, mirtazapine, vilazodone and vortioxetine

96
Q

What are augmentation stimulant strategies used for?

A

Atypical depression or sx of fatigue in tx-resistant depression

97
Q

What are the types of augmentation stimulants?

MOA, ADR

A

Methylphenidate and modafinil:
* MOA: Increases NE and DA actions by blocking re-uptake
* ADR: abuse potential

Amphetamine:
MOA: Increases NE and DA actions by blocking re-uptake
ADR: abuse potential

98
Q

Indications for St Johns wort?

A

Effective for mild-moderate depression
* Increases expression of intestinal P-gp and CYP3A4 in liver and intestine

99
Q

What is esketamine?

A

First non-monoamine-specific agent approved for MDD

100
Q

Esketamine

MOA, Onset, ADR

A

MOA: Noncompetitive antagonist of NMDA receptor
Onset: Rapid, but can produce dissociate sx and risk of
ADR: HTN, dissociative sx commin in the first 2 hr

101
Q

Electroconvulsive Therapy

Indication, MOA, ADR, Onset

A

Indication: Severe or life-threatening depression, and can’t take med
MOA: Increases sensitivity of postsynaptic 5-HT receptors and upregulation of 5-HT1A postsynaptic receptors
ADR: temporary short-term memory loss, headache
Onset: Quicker onset of response

102
Q

MOA of benzos?

A
103
Q

General characteristics of benzos?

A

Lipophillic -> high PPB, rapid absorption, half-life -> accumulation

104
Q

Common ADRs of benzos?

A
  1. Tolerance
  2. Abuse
  3. Withdrawal id DC abruptly
  4. risk of dependence, depression of
  5. CNS functions and amnestic effects
  6. Drowsiness, impaired judgement, diminished motor skills, anterograde amnesia
105
Q

Why are benzos good for anxiety?

A
  1. Rapid onset
  2. Relatively high TI
  3. Low risk of DDIs
  4. Minimal effects on cardiovascular/autonomic functions
  5. acute anxiety
106
Q

Describe benzo SAR?

A
107
Q

Types of benzos

A

Chlordiazepoxide
Diazepam (Valium)
Clorazepate
Oxazepam/Lorazepam (Ativan)

108
Q

Chlordiazepoxide

PK

A

PK: long half-life, active metabolites -> accumulation

109
Q

Diazepam

PK

A

Valium
PK: accumulation due to active metabolites

110
Q

Clorazepate

PK

A

Prodrug, polar but metabolite = nonpolar -> long half-life

111
Q

What is the difference between oxazepam and lorazepam?

A

Oxazepam: active metabolite of diazepam/chlordiazepoxide
* Short acting -> less accumulation and polar OH group
Lorazepam: 2’-chloro derivative of oxazepam

112
Q

What AD is preffered due to having more favorable ADRs?

A

SSRIs

113
Q

Buspirone

MOA, PK, ADR

A

MOA: Full agonist at presynaptic 5-HT1A receptor and partial agonist at postsynaptic 5-HT1A receptor
* Reduces hyperserotonergic tone in the brain

PK: axioselective, slower onset and not effective prn
ADR: Dizziness, nervousness, headache, tinnitus, GI distress, hallucinations, seizures

114
Q

Hydroxyzine

MOA, ADR

A

MOA: antihistamine
ADR: sedative

115
Q

Indications for b-blocks in depression and anxiety?

A

Good for symptom reduction: Reduce autonomic physiologic manifestations of anxiety

116
Q

Prazosin

MOA, Indication

A

MOA: a1 adrenergic antagonist (HTN and BPH)
Indication: Decreases occurrence of traumatic nightmares for PTSD